Goodwin, Fenwick Guide Incyte-Vega Deal Worth Up To $2B
The biotechnology company Incyte said Monday it has entered into a definitive agreement to acquire Vega Therapeutics Inc. from Star Therapeutics for up to $2 billion, with Goodwin Procter LLP advising...To view the full article, register now.
Already a subscriber? Click here to view full article